losartan and technetium

losartan has been researched along with technetium in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bjurgert, E; Cuthbertson, A; Hofstra, L; Indrevoll, B; Kindberg, GM; Krasieva, TB; Lovhaug, D; Narula, J; Narula, N; Petersen, LB; Petrov, AD; Reutelingsperger, CP; Solbakken, M; Tromberg, BJ; Vannan, MA; Verjans, JW	1
Blankesteijn, WM; Daemen, MJ; Fujimoto, A; Fujimoto, S; Hofstra, L; Isobe, S; Li, P; Lovhaug, D; Narula, J; Narula, N; Petrov, A; Pitt, B; Reutelingsperger, C; Smits, JF; van den Borne, SW; Vannan, MA; Wong, ND; Zandbergen, HR; Zannad, F	1

Other Studies

2 other study(ies) available for losartan and technetium

Article	Year
Noninvasive imaging of angiotensin receptors after myocardial infarction. JACC. Cardiovascular imaging, 2008, Volume: 1, Issue:3 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Binding Sites; Biomarkers; Disease Models, Animal; Feasibility Studies; Fluorescent Dyes; Heart Failure; Losartan; Male; Mice; Microscopy, Confocal; Microscopy, Fluorescence; Microscopy, Fluorescence, Multiphoton; Microscopy, Video; Myocardial Infarction; Myocardium; Radiopharmaceuticals; Receptors, Angiotensin; Technetium; Time Factors; Tomography, Emission-Computed, Single-Photon; Ventricular Remodeling; X-Ray Microtomography	2008
Molecular imaging for efficacy of pharmacologic intervention in myocardial remodeling. JACC. Cardiovascular imaging, 2009, Volume: 2, Issue:2 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Carbocyanines; Cardiovascular Agents; Disease Models, Animal; Drug Therapy, Combination; Echocardiography; Fibrillar Collagens; Fibroblasts; Fibrosis; Losartan; Mice; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Myocardium; Oligopeptides; Predictive Value of Tests; Spironolactone; Technetium; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left; Ventricular Remodeling	2009

Article

Year

Noninvasive imaging of angiotensin receptors after myocardial infarction.

JACC. Cardiovascular imaging, 2008, Volume: 1, Issue:3

Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Binding Sites; Biomarkers; Disease Models, Animal; Feasibility Studies; Fluorescent Dyes; Heart Failure; Losartan; Male; Mice; Microscopy, Confocal; Microscopy, Fluorescence; Microscopy, Fluorescence, Multiphoton; Microscopy, Video; Myocardial Infarction; Myocardium; Radiopharmaceuticals; Receptors, Angiotensin; Technetium; Time Factors; Tomography, Emission-Computed, Single-Photon; Ventricular Remodeling; X-Ray Microtomography

2008

Molecular imaging for efficacy of pharmacologic intervention in myocardial remodeling.

JACC. Cardiovascular imaging, 2009, Volume: 2, Issue:2

Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Carbocyanines; Cardiovascular Agents; Disease Models, Animal; Drug Therapy, Combination; Echocardiography; Fibrillar Collagens; Fibroblasts; Fibrosis; Losartan; Mice; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Myocardium; Oligopeptides; Predictive Value of Tests; Spironolactone; Technetium; Tomography, Emission-Computed, Single-Photon; Ventricular Function, Left; Ventricular Remodeling

2009